Subtype
Pancreatic Neoplasm
CI-CAN-00001356Explore in graph →
Non-malignant987 active trials8 approved drugs63 evidence items
Loading cancer entity…
Subtype
CI-CAN-00001356Explore in graph →
Clinical trials
4,216 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00005869 | Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer | unknown | Phase 3 | — | Astex Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00005870 | Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas | unknown | Phase 3 | — | Astex Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 4, 2013 |
| NCT00005871 | Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer | unknown | Phase 3 | — | Astex Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00003216 | Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas | completed | Phase 3 | 518 | Radiation Therapy Oncology GroupNETWORK | 2 | Nov 19, 2013 | clinicaltrials |
| NCT01931449 | Evaluation of A New Digestive Reconstruction Procedure Following Pancreatoduodenectomy | unknown | Phase 3 | 200 | Southwest Hospital, ChinaOTHER | 1 | Aug 29, 2013 | clinicaltrials |
| NCT00425360 | Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 3 | 1,110 | Royal Liverpool University HospitalOTHER_GOV | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00032175 | Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 3 | 508 | Cancer Research UKOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00088894 | Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 3 | 590 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00662688 | Chemotherapy With or Without Dalteparin in Treating Patients With Metastatic Pancreatic Cancer(PAM07) | terminated | Phase 3 | 42 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Mar 13, 2013 | clinicaltrials |
| NCT00033735 | Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer | completed | Phase 3 | 158 | Eisai Inc.INDUSTRY | 1 | Dec 24, 2012 | clinicaltrials |
| NCT00387348 | Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer | terminated | Phase 3 | 24 | Massachusetts General HospitalOTHER | 1 | Dec 3, 2012 | clinicaltrials |
| NCT00498225 | Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic Cancer(GEST) | completed | Phase 3 | 834 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 2 | Nov 2, 2012 | clinicaltrials |
| NCT01655641 | Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery(TMGS) | unknown | Phase 2 / Phase 3 | 118 | Tribhuvan University Teaching Hospital, Institute Of Medicine.OTHER | 1 | Oct 16, 2012 | clinicaltrials |
| NCT00064207 | Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer | completed | Phase 2 / Phase 3 | 97 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Sep 24, 2012 | clinicaltrials |
| NCT00440167 | Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine | unknown | Phase 3 | 280 | PD Dr. med. Volker HeinemannOTHER | 0 | Jul 9, 2012 | clinicaltrials |
| NCT00003029 | Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas | completed | Phase 3 | 200 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Jul 2, 2012 | clinicaltrials |
| NCT00024427 | Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer | completed | Phase 3 | 250 | Wellstat TherapeuticsINDUSTRY | 2 | Jun 28, 2012 | clinicaltrials |
| NCT00023972 | Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 3 | — | Daiichi SankyoINDUSTRY | 3 | May 16, 2012 | clinicaltrials |
| NCT00051467 | A Study of TNFerade™ Biologic With 5-FU and Radiation Therapy for First-Line Treatment of Unresectable Locally Advanced Pancreatic Cancer | completed | Phase 3 | — | GenVecINDUSTRY | 1 | Feb 23, 2012 | clinicaltrials |
| NCT00960284 | Gemcitabine or Combination Chemotherapy Followed by Chemoradiation for Stage IB, II, or III Pancreatic Cancer(PACT-7) | completed | Phase 2 / Phase 3 | 102 | IRCCS San RaffaeleOTHER | 1 | Jan 13, 2012 | clinicaltrials |
| NCT00058149 | Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 3 | — | Eastern Cooperative Oncology GroupNETWORK | 2 | Sep 21, 2011 | clinicaltrials |
| NCT00005648 | Gemcitabine With or Without Tipifarnib (R115777) in Treating Patients With Advanced Pancreatic Cancer | completed | Phase 3 | 688 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 0 | May 19, 2011 | clinicaltrials |
| NCT01330823 | L-CARnitine in the Palliative Treatment of Advanced PANcreatic Cancer (CARPAN)(CARPAN) | suspended | Phase 3 | 72 | University Medicine GreifswaldOTHER | 1 | Apr 7, 2011 | clinicaltrials |
| NCT00192712 | Irinotecan, Gemcitabine and Radiation Therapy for Pancreatic Cancer | completed | Phase 2 / Phase 3 | 20 | Rambam Health Care CampusOTHER | 1 | Nov 10, 2010 | clinicaltrials |
| NCT00428597 | A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors | terminated | Phase 3 | 171 | PfizerINDUSTRY | 11 | Oct 11, 2010 | clinicaltrials |
| NCT00014651 | Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection | terminated | Phase 3 | — | Mayo ClinicOTHER | 1 | Aug 10, 2010 | clinicaltrials |
| NCT00541021 | Gemcitabine With or Without Sorafenib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | unknown | Phase 3 | 104 | Institut Paoli-CalmettesOTHER | 1 | Dec 15, 2009 | clinicaltrials |
| NCT00099294 | Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer | completed | Phase 3 | 300 | Threshold PharmaceuticalsINDUSTRY | 11 | Apr 30, 2009 | clinicaltrials |
| NCT00813696 | Gemcitabine or Gemcitabine and Cisplatin in the Treatment of Advanced Pancreatic Cancer(GIP-1) | unknown | Phase 3 | 400 | Istituti Tumori Giovanni Paolo IINETWORK | 1 | Dec 23, 2008 | clinicaltrials |
| NCT00809081 | Early Enteral Feeding After Pylorus Preserving Pancreatoduodenectomy | unknown | Phase 3 | 38 | Yonsei UniversityOTHER | 1 | Dec 16, 2008 | clinicaltrials |
| NCT00075452 | Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma | unknown | Phase 3 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00268411 | Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer | unknown | Phase 3 | 80 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | May 27, 2008 | clinicaltrials |
| NCT00358566 | GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic Cancer | terminated | Phase 3 | 360 | Pharmexa A/SINDUSTRY | 12 | May 19, 2008 | clinicaltrials |
| NCT00644618 | Randomized Controlled Trial of Gemcitabine Combined With 125I Brachytherapy | completed | Phase 3 | 120 | Huazhong University of Science and TechnologyOTHER | 0 | Mar 27, 2008 | clinicaltrials |
| NCT00040092 | A Study to Test the Effectiveness of Virulizin® Given in Combination With Standard Chemotherapy for Pancreatic Cancer | completed | Phase 3 | 400 | Aptose Biosciences Inc.INDUSTRY | 0 | Jan 7, 2008 | clinicaltrials |
| NCT00486460 | Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer | unknown | Phase 3 | — | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Jun 14, 2007 | clinicaltrials |
| NCT00136669 | Acupuncture For Pancreatic Cancer Pain | completed | Phase 3 | 60 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 8, 2006 | clinicaltrials |
| NCT00035035 | A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas. | completed | Phase 3 | — | Eli Lilly and CompanyINDUSTRY | 18 | Jul 19, 2006 | clinicaltrials |
| NCT00088660 | PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen | unknown | Phase 3 | 250 | Therion Biologics CorporationINDUSTRY | 1 | Feb 8, 2006 | clinicaltrials |
Data updated 22 days agoSource updated Dec 4, 2013source: clinicaltrials